Introduction
Intracranial schwannomas are common neoplasms, accounting for 8-10% of all primary intracranial neoplasms. [1, 2] Tumors in the cerebellopontine angle account for 5-10% of all intracranial tumors. [3] In the cerebellopontine angle, vestibular schwannoma (VS) is the most common lesion, contributing to 80% of all tumors. [2, 4, 5] The occurrence of cysts within VS outcome, and poor surgical outcome with higher incidence of subtotal tumor excision.
In this study, we present our series of 64 patients with cystic VS treated surgically. The aim was to analyze the clinical characteristics to assess facial nerve preservation and operative outcome of surgically treated cystic VS. We compare our results with other series on cystic VS with regard to clinical manifestations and surgical morbidity.
Materials and Methods
A total of 488 cases of vestibular schwannomas were surgically managed during the period from January 1998 to December 2008 at our institute. Among these, 64 patients (13.1%) were diagnosed to have cystic VS on neuroimaging. We defined cystic VS as one, in which the cyst component constituted greater than 50% of the solid component on imaging calculated as percentage of volume.
Case records were reviewed to analyze data such as patient demographics, symptoms and signs at presentation, and the presence of preoperative cranial nerve deficits. Audiometry charts were evaluated, and extent of hearing loss was documented using the Gardner Robertson classification. Radiological investigations including CT and/or MR images were examined for estimating tumor size by measuring the mean maximum anteroposterior and mediolateral diameters. Cysts were classified according to Piccirillo's classification, [1] which identified cystic VS as follows:
Type A -central and thick-walled cysts, which were further subdivided as 1. Polycystic (multiple small intra-tumoral cysts with thick cyst wall) 2. Polycystic (multiple moderate-sized intra-tumoral cysts with thick cyst wall) 3. Monocystic (single large cyst) Type B -peripheral and thin-walled cysts 1 -Anterior, 2 -Medial, 3 -Posterior, 4 -Combined.
All patients underwent tumor excision through retrosigmoid sub-occipital approach in lateral position by the senior author (S.N). Standard microsurgical techniques were used in all patients. Adjuncts like cavitron ultrasonic surgical aspirator and facial nerve monitoring were used in cases operated after 2004 when it became available in our hospital. Operation records were analyzed for type of tumor and anatomical preservation of facial nerve. The extent of tumor removal was classified as either total or subtotal depending on the intra-operative impression of the surgeon and post-operative imaging. Surgical morbidity was assessed in terms of Glasgow outcome scale.
The pre-operative and post-operative facial nerve function at discharge, 6 months, and at follow-up on was recorded according to the House Brackmann (HB) classification system. An attempt was made to see if any correlation exists between the type of cyst based on Piccirillo's classification [1] and facial nerve outcome at 6 months. Patients were grouped into three depending on the degree of facial nerve palsy: Significant figures Suggestive significance (P value: 0.05 < P < 0.10) Moderately significant (P value: 0.01 < P ≤ 0.05) Strongly significant (P value: P ≤ 0.01)
Results
Age ranged from 17 years to 72 years with the mean age being 45.5 years. The most common age group was in fourth decade (31.2%) followed by fifth decade (26.6%). There were 30 males (46.9%) and 34 (53.1%) females in the study population. The most common initial symptom was progressive hearing impairment in 49 (76.6%) patients. Atypical initial symptoms were present in 15 (23.4%) patients [ Table 1 ]. Table 2 shows the clinical symptoms and signs at presentation. Mean duration of initial symptoms was 18 months (range: 1-68 months), being shortest for lower cranial and facial nerve palsy (3.29 and 4.47 months, respectively) as shown in [Table 3 ]. Preoperatively, 78% patients had good facial nerve function (HB grade 1 and 2) while 22% of patients had intermediate (HB grade 3 and 4) to poor (HB grade 5 and 6) facial nerve function.
All patients underwent pre-operative imaging namely, CT in 12, MR imaging in 13, or both in 39 patients. In general, non-contrast CT revealed isodense tumors with areas of [1] [ Table 4 ]. Type A2 and B4 contributed 37.5% and 14.2% according to Piccirillo classification. [1] Complete tumor removal was achieved in 53 patients (83%). Eleven patients (17%) underwent subtotal removal due to extensive adherence to brainstem, lower cranial nerves, or the facial nerve. In 26 patients (40.6%), the facial nerve could not be preserved. The facial nerve was intact but thinned out in 38 patients (59.4%). Post-operative CSF diversion was necessary in 4 patients (6.3%) in view of symptomatic hydrocephalus. Overall, there was no post-operative mortality defined as death within 30 days of surgery. However, 1 patient died due to sepsis, following aspiration pneumonia, 4 months after surgery.
Follow-up period ranged from 6 months to 13 years (mean: 4.8 years). Twelve patients were lost to follow-up after 6 months. Table 5 demonstrates facial nerve function prior to surgery, at 6 months, and on follow-up. Good facial nerve function was seen in 78% patients prior to surgery while at 6 months and on follow up, 90% patients had either intermediate or poor facial nerve function. In patients with anatomical preservation of facial nerve, two third of patients had HB grade 4 and 5 facial palsy, 6 months after 
Discussion
Cystic VS are a subgroup of VS with unique clinical, imaging features, and surgical outcome. The incidence of cystic VS varies depending on what percentage of cysts constitutes VS. In the present series, the incidence of cystic VS (13.1%) closely corresponds to Kameyama et al. [5] series (13.5%).
The pathogenesis of cysts within VS is not definitely known. Several postulates have been proposed for mechanism of cyst formation and enlargement. Cyst formation is due to coalescence of microcysts in Antoni type B tissue with surgery. Higher-grade facial palsy at 6 months (4, 5, and 6) was associated with giant cystic VS [ Table 6 ]. Unfavorable grade of facial palsy was seen more often in Piccirillo's type B cysts (90%) as compared to type A cyst (74%) [ Table 4 ]. Though P value did not reach statistical significance, it was suggestive of significance. Post-operative complications included pseudomeningocele in 4 patients, paradoxical CSF
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Vol. 11, Issue 3, July-September 2016 compressed surrounding Antoni type A tissue. [2, 5, 7, [18] [19] [20] [21] Thus, enlargement is mainly due to the expansion of the cyst component rather than high growth rate of tumor cells. [18, 21, 22] Extravasation of serum proteins from an impaired blood tumor barrier or protein secretion from tumor cells can lead to cyst enlargement due to an osmotic effect. Intra-tumoral cyst may also arise from previous bleeding within the lesion or following repeated microhemorrhages as evidenced by hemosiderin-laden macrophages, hemosiderin deposits, and abnormal vessel proliferation. [2, 21, 23] The rapid clinical worsening or acute evolution of symptoms in cystic VS is due to sudden expansion of cysts, causing compression of surrounding structures, distortion of the brain-stem, stretching the cranial nerves, and a rapid rise of intracranial pressure that results in significant neurological deficits before compensatory mechanisms occur. [4, 16, 24] It is known that the level of matrix metalloproteinase 2 (MMP 2) is higher in the cyst fluid. This results in peritumoral adhesions, as the tumor-nerve barrier is impaired, leading to different clinical and surgical outcome. [6] Cystic VS tend to present with atypical initial symptoms like facial pain or facial palsy rather than hearing loss. In our series, nearly one-fifth presented with atypical initial symptoms, mainly unsteadiness of gait, headache, facial pain, numbness, and dysguesia attributable to the rapidly expanding cysts rather than tumor size alone. The most common initial symptom was hearing loss (76.5%). Benech et al. [4] also reported a high incidence (81%) of hearing loss as an initial symptom. The mean duration of overall symptoms in this study was 15 months, comparable to the series by Moon et al. [6] and Sinha et al. [3] (14 and 16 months, respectively). Table 7 provides an overall comparison of our study findings with that published in literature. Pre-operative facial palsy observed in 56.2% patients was comparable to that observed in Kameyama et al. [5] study (64.2%). This is in contrast to the articles by Wandong et al. [2] and El Bahy et al. [25] where they reported a less than 20% incidence of pre-operative facial palsy. The highest incidence has been reported by Sinha et al. [3] Cystic VS are large in size (>3 cm) and frequently giant (>4 cm) at presentation. Our mean tumor size of 4.1 cm is comparable to other series [ Table 7 ].
Cystic VS lack the typical radiological features of VS like erosive enlargement of internal auditory canal or enhancement of intra-canalicular portion. [5] Enhancement surrounding the cyst on Gadolinium administration is due to the presence of enveloping tumor tissue and/or inflammatory reaction to the fluid contents of the cyst. [11, 16] The presence of fluid-fluid levels and hemosiderin deposits suggests microhemorrhages as possible cause for cyst formation. [21] The occurrence of obstructive hydrocephalus requiring CSF diversion is less frequent in cystic VS. [4] One possible explanation is that cysts deform to the shape of the surrounding neural structures rather than causing compression on them. [4] Pre-operative CSF diversion was done in 12.5% of patients in our series that is substantially less compared to reports by El Bahy et al. [25] and Benech et al. [4] (23% and 27%, respectively). Sinha et al. [3] had the highest incidence of pre-operative CSF diversion (48.3%), probably due to a high mean tumor size.
Treatment
The treatment options for VS include observation, surgical excision, or radiosurgery. The "wait and scan" policy is not recommended in cystic VS, as rapid expansion of cyst elements can cause acute neurological deterioration. Though conflicting views exist over the surgical outcome in cystic VS with respect to facial nerve, [5, 15, 24, 26, 27] it is now generally accepted that the occurrence of cysts in VS is predictive of a worse surgical outcome as compared to its solid counterpart of similar size. [4, 6, 22, 24, [28] [29] [30] Even though surgery in cystic VS may appear to be easy and quick in terms of initial debulking than in solid tumor, there is a high incidence of accidental facial nerve injury. This is due to peri-cyst adhesions with absence of adequate tumor-arachnoid dissection plane, especially if the cysts are located anteriorly in intimate relation to the facial nerve. [1, 5, 6, 29] The facial nerve may also be displaced in a different position depending on the pattern of cyst growth. In solid tumors, the nerve is almost constantly in a lower anterior position. [31] The solid portion in cystic VS is more vascular, leading to greater chances for intra-operative bleeding. However, Jones et al. [14] concluded that worse facial nerve outcome following surgery for cystic VS is due to their size and not due to the presence of a cysts per se. Samii et al. [30] reported that the rate of anatomic facial nerve preservation decreases from 93% in solid tumors to 88% in cystic VS. Hence, total resection with preservation of the facial nerve is more difficult. [2] Sharp dissection technique to separate the peritumoral adherences must be employed to avoid traction on facial nerve. [4] Though the overall surgical goal is total tumor excision, cystic VS may be partially excised so that anatomical integrity of facial nerve can be preserved.
In the present series, total excision of the tumor was possible in 83% cases, comparable to several published series. [1] [2] [3] 5, 16] Moon et al. [6] reported complete excision in all cystic VS. Following surgery in the present series facial nerve function at 6 months was satisfactory (HB grade 1-3) in only 21% of patients. This is in contrast to other series, in which satisfactory facial nerve function was seen in 60-80% of patients. [1] [2] [3] In patients with anatomical preservation of facial nerve, good outcome (HB grade 1-3) was seen in 34% of patients. The higher incidence of poor facial nerve function in the present study is probably due to large and giant tumors and an attempt at complete tumor removal. The use of intra-operative facial monitoring also is an extremely useful adjunct, especially in cystic VS. We had a much higher incidence of post-operative facial nerve palsy prior to facial monitoring. This has also contributed to an overall poor facial nerve preservation outcome. We believe that portions of the cyst wall firmly adherent to the nerve should be left behind rather than achieve total tumor removal. Based on post-operative imaging, residual tumors can be sent for radiotherapy. Now, the use of three-dimensional (3D) constructive interference in steady state (CISS) sequence in MRI can help preoperatively track to course of the facial nerve, thus increasing the prospects of nerve preservation.
Piccirillo et al. [1] concluded that in peripherally located, thin-walled anteriorly and medially placed cysts (Type B), subtotal resection is frequently advocated, leaving a portion of the cyst wall on the brainstem and facial nerve. Complete resection can often be achieved in purely posterior cysts and type A cysts.
Radiosurgery is not the ideal treatment modality in cystic VS due to large tumor size and cystic contents. [12, 25, 32] Radiosurgery usually results in sustained expansion, causing cyst rupture, sustained regression, or transient expansion followed by sustained regression or no change. [32, 33] Cystic VS that has regressed after radiosurgery is still at risk for expansion, which needs close monitoring even years after radiosurgery. [34, 35] Surgery after failed radiation therapy is more difficult to perform because intense scarring and fibrosis obscures surgical planes, resulting in an indistinct facial nerve-tumor capsule interface and poor facial nerve outcome. [36] Recently, image-guided insertion of a valveless cystoperitoneal shunt as a palliative procedure in elderly patients who are at high risk for traditional surgical approaches has been described. [37] Though cystic VS have low proliferative index, residual cystic VS show rapid re-growth and require re-operation as compared to residual solid VS that have slow growth potential. [28] Recurrent cystic VS are even more surgically challenging, as they are associated with small chance of complete tumor removal and facial nerve preservation.
Conclusion
Cystic VS are a heterogenous group of VS presenting with short duration and rapid progression of symptoms with frequent facial nerve involvement due to sudden expansion of the cystic elements. Particular attention should be given to preservation of facial nerve though it may be technically difficult. Resection of cystic VS is complicated by peritumoral adhesions of the capsule to the nerve and large size of the tumor. Extensive manipulation of the nerve in order to dissect the tumor-nerve barrier results in worse facial nerve outcome and poor health-related quality of life. Facial nerve outcome is worse in type B cysts (peripheral located and thin-walled cyst) as compared to type A cysts (centrally located and thick-walled cyst). Subtotal excision may be ideal, especially in type B anterior and medially placed cysts, in order to preserve facial nerve integrity. 
